Le marché de la biologie synthétique devrait passer de 10 544,16 millions de dollars américains en 2021 à 37 850,85 millions de dollars américains d'ici 2028 ; on estime qu'il croîtra à un TCAC de 20,0 % de 2021 à 2028.
La biologie synthétique médicale est la science de la conception, de la modification et de la construction d'organismes simples pour effectuer des traitements ou des traitements spécifiques. utilités industrielles. Les organismes créés sont des organismes génétiquement modifiés (OGM), qui ne nécessitent pas de définition les distinguant des modifications génétiques. La croissance du marché de la biologie synthétique est attribuée à l'augmentation des investissements, aux progrès technologiques et au nombre croissant de start-up. De plus, les tendances émergentes en biologie synthétique sont susceptibles d'avoir un impact positif sur la croissance du marché dans les années à venir.
Insights stratégiques
Le marché de la biologie synthétique est segmenté en produit, technologie, application et géographie. Par géographie, le marché est largement segmenté en Amérique du Nord, en Europe, en Asie-Pacifique, au Moyen-Orient et en Afrique et en Amérique du Sud et centrale. Le rapport sur le marché de la biologie synthétique offre des informations et une analyse approfondie du marché, mettant l'accent sur les tendances du marché, les avancées technologiques, la dynamique du marché et l'analyse concurrentielle des principaux acteurs du marché mondial.
Régions lucratives pour le marché de la biologie synthétique
L'augmentation des investissements dans la biologie synthétique stimule le marché de la biologie synthétique
La biologie synthétique est un concept émergent qui a de nombreuses applications dans les industries chimiques, agricoles, pharmaceutiques et énergétiques. Diverses start-up proposent des produits/services de synthèse de gènes pour des processus biologiques. Par exemple, Benchling fournit des outils de CAO, GenScript propose la synthèse de gènes, Ginkgo Bioworks aide à l'ingénierie des organismes, Transcripts (une société de bioinformatique) propose des solutions facilitant les laboratoires cloud/l'automatisation, et Glowee propose des produits grand public. En outre, 56 entreprises de biologie synthétique ont levé plus de 3 milliards de dollars US en financement par actions au premier semestre 2020, contre 65 entreprises ayant levé 1,9 milliard de dollars US au cours de la même période en 2020. La nouvelle génération d'entreprises biopharmaceutiques utilise la biologie synthétique pour améliorer le traitement cellulaire et la thérapie génique et soutenir la détection précoce du cancer. Certaines entreprises de biologie synthétique les plus financées au premier semestre 2020 sont répertoriées ci-dessous :
Entreprises de biologie synthétique les plus financées au premier semestre 2020
< TIP>
Insights sur les produits
Sur la base des produits, le marché mondial de la biologie synthétique est segmenté en oligonucléotides, organismes châssis, enzymes et acide xénonucléique. Le segment des oligonucléotides détenait la plus grande part du marché en 2021. De plus, le même segment devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision de 2021 à 2028. Cela est principalement dû à l'application croissante des oligonucléotides dans les tests génétiques. / essais et sciences médico-légales.
Marché de la biologie synthétique, par produit (2021-2028)
Perspectives technologiques
< CONSEIL>Basé sur la technologie, le marché mondial de la biologie synthétique est segmenté en synthèse de gènes, ingénierie du génome, mesure et modélisation, clonage et séquençage, nanotechnologie et autres. En 2021, le segment de la synthèse de gènes devrait détenir la plus grande part du marché. Cependant, le segment de l'ingénierie du génome devrait enregistrer le TCAC le plus élevé de 2021 à 2028. La croissance du segment de l'ingénierie du génome est due aux applications croissantes du génie génétique et de la thérapie génique.
Application Insights
Sur la base des applications, le marché mondial de la biologie synthétique est segmenté en applications médicales, applications industrielles, applications environnementales, alimentation et l'agriculture, et d'autres. Le segment des applications médicales est en outre segmenté en découverte de médicaments et thérapeutique et produits pharmaceutiques. En 2021, le segment des applications médicales détenait la plus grande part de marché et devrait enregistrer le TCAC le plus élevé au cours de la période 2021-2028.
Les lancements de produits et les collaborations sont des stratégies très adoptées par les acteurs mondiaux du marché de la biologie synthétique. Quelques-uns des développements clés récents du marché sont répertoriés ci-dessous :
- En février 2022, Thermo Fisher Scientific a annoncé le lancement de GeneMapper Software, un progiciel de génotypage flexible qui fournit un dimensionnement de l'ADN et des appels d'allèles de qualité pour tous les génotypages basés sur l'électrophorèse Thermo Fisher Scientific.
- En janvier 2022, Thermo Fisher Scientific a annoncé le lancement d'Oncomine BRCA Assay GX. Il s'agit d'un test de séquençage ciblé de nouvelle génération (NGS) conçu pour fournir une amplification complète de toutes les régions codantes des gènes BRCA1 et BRCA2 humains, permettant une détection précise et sensible de diverses classes de mutations.
- Dans Avril 2022, Merck KGaA Acquisition de la plate-forme MAST de Lonza, un système d'échantillonnage de bioréacteur automatisé de premier plan. L'acquisition de la plate-forme MAST est une autre étape importante pour accélérer l'innovation dans l'unité commerciale Mercks Process Solutions.
- En février 2022, Merck a annoncé la clôture de la transaction pour acquérir Exalead, à la suite des autorisations réglementaires et de l'accomplissement d'autres conditions de clôture habituelles, pour environ 780 millions de dollars américains en espèces.
La pandémie de COVID-19 a forcé de nombreuses entreprises du marché mondial de la biologie synthétique à suspendre leurs activités opérations à court terme pour suivre les nouvelles réglementations gouvernementales visant à contrôler la propagation de la maladie. Cet arrêt des opérations a eu un impact direct sur le flux de revenus du marché mondial de la biologie synthétique. De plus, la fabrication de produits industriels a cessé, faute de matières premières et de main-d'uvre pendant la période de confinement. En outre, aucun nouvel envoi n'a été reçu par les entreprises qui opèrent dans ce secteur. Ainsi, plusieurs mois d'arrêt des activités industrielles et de confinement ont affecté l'industrie mondiale de la biologie synthétique. L'épidémie de COVID-19 a affecté la croissance de l'industrie de la biologie synthétique en raison des mesures de confinement dans les pays et du retard dans la fabrication et la production de matières premières, de matériaux de transformation et de produits intermédiaires utilisés dans les entreprises pharmaceutiques et biotechnologiques. Le marché devrait connaître une lente reprise au cours de la période de prévision.
Biologie synthétique - Segmentation du marché
Le marché mondial de la biologie synthétique est segmenté en fonction du produit, de l'application technologique et de la géographie. Sur la base du produit, le marché est segmenté en oligonucléotides, organismes châssis, enzymes et acide xénonucléique. Basé sur la technologie, le marché de la biologie synthétique est segmenté en synthèse de gènes, ingénierie du génome, mesure et modélisation, clonage et séquençage, nanotechnologie et autres. Sur la base des applications, le marché de la biologie synthétique est segmenté en applications médicales, applications industrielles, applications environnementales, alimentation et agriculture, etc. Par géographie, le marché de la biologie synthétique est segmenté en Amérique du Nord, en Europe, en Asie-Pacifique, au Moyen-Orient et en Afrique et en Amérique du Sud et centrale.
Profils des entreprises
- THERMO FISHER SCIENTIFIC INC.
- Agilent Technologies, Inc.
- MERCK KGaA
- New England Biolabs
- Technologies ADN intégrées
- GenScript Biotech Corporation
- Novozymes A/S
- Codexis
< li>Twist Bioscience
< li>Amyris Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
As per application, the medical applications segment is accounted to grow at the fastest CAGR in the market during the forecast period.
The synthetic biology market majorly consists of the players such as Thermo Fisher Scientific
Agilent technologies; Merck KGaA; New England Biolabs; Integrated DNA Technologies; Twists Bioscience; Genscript Biotech corporation; Novozymes A/S; Codexis; Amyris among others.
The oligonucleotides segment held the largest revenue share in 2021.
Synthetic biology is a science of designing, altering and building simple organisms to perform specific therapeutic or industrial utilities. The commercialization or industrialization of biology renders processes quicker, cheaper and reliable. The organisms created are known as genetically modified organisms (GMOs), which do not require a definition that distinguishes it from genetic modifications.
The List of Companies - Synthetic Biology Market
- Thermo Fisher Scientific
- Agilent technologies
- Merck KGaA
- New England Biolabs
- Integrated DNA Technologies
- Twists Bioscience
- Genscript Biotech corporation
- Novozymes A/S
- Codexis
- Amyris
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2022
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2022
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2022
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2022
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2022
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2022
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)